chr18-22936966-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002894.3(RBBP8):​c.109+6A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00158 in 1,613,832 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 18 hom. )

Consequence

RBBP8
NM_002894.3 splice_region, intron

Scores

2
Splicing: ADA: 0.00001176
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.250

Publications

1 publications found
Variant links:
Genes affected
RBBP8 (HGNC:9891): (RB binding protein 8, endonuclease) The protein encoded by this gene is a ubiquitously expressed nuclear protein. It is found among several proteins that bind directly to retinoblastoma protein, which regulates cell proliferation. This protein complexes with transcriptional co-repressor CTBP. It is also associated with BRCA1 and is thought to modulate the functions of BRCA1 in transcriptional regulation, DNA repair, and/or cell cycle checkpoint control. It is suggested that this gene may itself be a tumor suppressor acting in the same pathway as BRCA1. Three transcript variants encoding two different isoforms have been found for this gene. More transcript variants exist, but their full-length natures have not been determined. [provided by RefSeq, Jul 2008]
RBBP8 Gene-Disease associations (from GenCC):
  • Jawad syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • Seckel syndrome 2
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
  • Seckel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 18-22936966-A-G is Benign according to our data. Variant chr18-22936966-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 212018.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00121 (184/152328) while in subpopulation SAS AF = 0.0116 (56/4830). AF 95% confidence interval is 0.00917. There are 0 homozygotes in GnomAd4. There are 96 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 18 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RBBP8NM_002894.3 linkc.109+6A>G splice_region_variant, intron_variant Intron 2 of 18 ENST00000327155.10 NP_002885.1 Q99708-1A0A024RC34

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RBBP8ENST00000327155.10 linkc.109+6A>G splice_region_variant, intron_variant Intron 2 of 18 1 NM_002894.3 ENSP00000323050.5 Q99708-1

Frequencies

GnomAD3 genomes
AF:
0.00121
AC:
184
AN:
152210
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00177
Gnomad ASJ
AF:
0.0138
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.0116
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000661
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00292
AC:
733
AN:
250946
AF XY:
0.00354
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.00121
Gnomad ASJ exome
AF:
0.0121
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00105
Gnomad OTH exome
AF:
0.00310
GnomAD4 exome
AF:
0.00161
AC:
2358
AN:
1461504
Hom.:
18
Cov.:
30
AF XY:
0.00207
AC XY:
1507
AN XY:
727050
show subpopulations
African (AFR)
AF:
0.000119
AC:
4
AN:
33476
American (AMR)
AF:
0.00119
AC:
53
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0129
AC:
337
AN:
26126
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39676
South Asian (SAS)
AF:
0.0135
AC:
1164
AN:
86252
European-Finnish (FIN)
AF:
0.0000188
AC:
1
AN:
53186
Middle Eastern (MID)
AF:
0.00780
AC:
45
AN:
5768
European-Non Finnish (NFE)
AF:
0.000550
AC:
612
AN:
1111916
Other (OTH)
AF:
0.00234
AC:
141
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
139
278
418
557
696
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00121
AC:
184
AN:
152328
Hom.:
0
Cov.:
32
AF XY:
0.00129
AC XY:
96
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.0000962
AC:
4
AN:
41564
American (AMR)
AF:
0.00176
AC:
27
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0138
AC:
48
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5192
South Asian (SAS)
AF:
0.0116
AC:
56
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000661
AC:
45
AN:
68036
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
12
24
36
48
60
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00128
Hom.:
1
Bravo
AF:
0.00113
Asia WGS
AF:
0.00289
AC:
10
AN:
3478
EpiCase
AF:
0.00191
EpiControl
AF:
0.00178

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Oct 06, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RBBP8: BP4, BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Feb 26, 2016
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

RBBP8-related disorder Benign:1
May 10, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
7.3
DANN
Benign
0.73
PhyloP100
-0.25
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000012
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149189755; hg19: chr18-20516929; API